Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?


Journal

Current opinion in organ transplantation
ISSN: 1531-7013
Titre abrégé: Curr Opin Organ Transplant
Pays: United States
ID NLM: 9717388

Informations de publication

Date de publication:
01 06 2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

New chronic lung allograft dysfunction (CLAD) consensus documents were published in 2019, defining four phenotypes; bronchiolitis obliterans syndrome, restrictive allograft syndrome, mixed and undefined. Clearly, validation of these guidelines in a real life cohort is critical. Indeed, validation has been performed recently, both after bilateral lung transplantation (LTx) and after single LTx illustrating that precise phenotyping based on pulmonary function alone can be difficult. Undertaking regular chest computed tomography scanning does appear very helpful in establishing the prognosis of the patients with CLAD. Pulmonary function changes may not always identify the exact phenotype of CLAD and we provide further evidence for the important role of chest imaging at diagnosis and during the follow-up of patients with CLAD.

Identifiants

pubmed: 35649111
doi: 10.1097/MOT.0000000000000962
pii: 00075200-202206000-00009
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-216

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Chambers DC, Perch M, Zuckermann A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report – 2021; focus on recipient characteristics. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021; 40:1060–1072.
Glanville A. Bronchoscopic monitoring after lung transplantation. Semin Respir Crit Care Med 2010; 31:208–221.
Verleden GM, Raghu G, Meyer KC, et al. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014; 33:127–133.
Verleden GM, Glanville AR, Lease ED, et al. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment - a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 2019; 38:493–503.
Todd JL. Putting the 2019 CLAD consensus definitions to the test: two steps forward, one step back? J Heart Lung Transplant 2020; 39:771–773.
Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12:713–716.
Sato M, Waddell TLK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel manifestation of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30:735–742.
Glanville AR, Verleden GM, Todd JL, et al. Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome - a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 2019; 38:483–492.
Verleden SE, Von Der Thusen J, Van Herck A, et al. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: a single-center study. Clin Transplant 2020; 34:e13781.
Levy L, Huszti E, Renaud-Picard B, et al. Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system. J Heart Lung Transplant 2020; 39:761–770.
Fuchs E, Levy L, Renaud-Picard B, et al. Significance of phenotype change after chronic lung allograft dysfunction onset. Transplant Int 2021; 34:2620–2632.
Li D, Weinkauf J, Kapasi A, et al. Baselinelungallograftdysfunctioninprimarygraft dysfunction survivors after lung transplantation. Respir Med 2021; 188:106617.
Hoang-Thi T, Chassagnon G, Hua-Huy T, et al. Chronic lung allograft dysfunction post lung transplantation: a review of computed tomography quantitative methods for detection and follow up. J Clin Med 2021; 10:1608–1618.
Brun A, Chabi M, Picard C, et al. Lung transplantation: CT assessment of chroniclungallograftdysfunction (CVLAD). Diagnostics 2021; 11:817–828.
Leuschner G, Lauseker M, Howanietz A, et al. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction. J Heart Lung Transplant 2020; 39:1270–1278.

Auteurs

Geert M Verleden (GM)

Department of Respiratory Diseases and Lung Transplantation Unit, University Hospital Gasthuisberg.
CHROMETA Department, Breathe Lab, KU Leuven, Leuven.

Laurent Godinas (L)

Department of Respiratory Diseases and Lung Transplantation Unit, University Hospital Gasthuisberg.
CHROMETA Department, Breathe Lab, KU Leuven, Leuven.

Robin Vos (R)

Department of Respiratory Diseases and Lung Transplantation Unit, University Hospital Gasthuisberg.
CHROMETA Department, Breathe Lab, KU Leuven, Leuven.

Stijn E Verleden (SE)

Department of Thoracic and Vascular Surgery & Pneumology UZA, University Hospital Antwerp, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH